Related Experiment Videos
Analgesia produced by E-2078, a systemically active dynorphin analog, in mice
T Nakazawa1, Y Furuya, T Kaneko
1Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan.
Summary
E-2078, a stable dynorphin analog, effectively reduces pain through kappa-opioid receptor activation. This systemic analgesic shows long-lasting effects in mice without impairing motor function.
Area of Science:
- Pharmacology
- Neuroscience
- Analgesics
Background:
- Dynorphin analogs are investigated for pain management.
- Understanding opioid receptor interactions is crucial for developing effective analgesics.
Purpose of the Study:
- To characterize the receptor selectivity of E-2078.
- To evaluate the systemic analgesic effects of E-2078 in mice.
Main Methods:
- In vitro receptor binding assays (mu, delta, kappa).
- In vivo analgesic tests (tail pinch, tail flick, formalin) in mice.
- Assessment of motor function using rotarod test.
- Reversal studies using naloxone and nor-binaltorphimine.
Main Results:
- E-2078 demonstrated higher affinity for kappa-opioid receptors compared to mu and delta receptors.
- Systemic administration of E-2078 produced dose-related, long-lasting analgesia in mice.
- The analgesic effect was observed without affecting motor coordination.
- E-2078-induced analgesia was partially reversed by naloxone and significantly antagonized by the kappa-opioid antagonist nor-binaltorphimine.
Conclusions:
- E-2078 is a systemically active analgesic agent.
- Activation of kappa-opioid receptors plays a significant role in the analgesic effects of E-2078.